PT  - JOURNAL ARTICLE
AU  - Bethel, M. Angelyn
AU  - Price, Hermione C.
AU  - Sourij, Harald
AU  - White, Sarah
AU  - Coleman, Ruth L.
AU  - Ring, Arne
AU  - Kennedy, Irene E.C.
AU  - Tucker, Lynne
AU  - Holman, Rury R.
TI  - Evaluation of a Self-Administered Oral Glucose Tolerance Test
AID  - 10.2337/dc12-0643
DP  - 2013 Jun 01
TA  - Diabetes Care
PG  - 1483--1488
VI  - 36
IP  - 6
4099  - http://care.diabetesjournals.org/content/36/6/1483.short
4100  - http://care.diabetesjournals.org/content/36/6/1483.full
SO  - Diabetes Care2013 Jun 01; 36
AB  - OBJECTIVE To assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community setting.RESEARCH DESIGN AND METHODS Eighteen healthy and 12 type 2 diabetic volunteers underwent six 75-g OGTTs using a prototype device in the following three settings: unaided at home (twice); unaided but observed in clinic (twice); and performed by a nurse with simultaneous laboratory glucose assays of 0- and 120-min venous plasma samples (twice). The device displayed no results. A detachable data recorder returned to the clinic provided plasma-equivalent 0- and 120-min glucose values and key parameters, including test date, start and end times, and time taken to consume the glucose drink.RESULTS The device was universally popular with participants and was perceived as easy to use, and the ability to test at home was well liked. Device failures meant that 0- and 120-min glucose values were obtained for only 141 (78%) of the 180 OGTTs performed, independent of setting. Device glucose measurements showed a mean bias compared with laboratory-measured values of +0.9 at 5.0 mmol/L increasing to +4.4 at 15.0 mmol/L. Paired device glucose values were equally reproducible across settings, with repeat testing showing no training effect regardless of setting order.CONCLUSIONS Self-administered OGTTs can be performed successfully by untrained individuals in a community setting. With improved device reliability and appropriate calibration, this novel technology could be used in routine practice to screen people who might need a formal OGTT to confirm the presence of impaired glucose tolerance or diabetes.